Focus on veno-venous ECMO in adults with severe ARDS
Focus on veno-venous ECMO in adults with severe ARDS
复制标题
重点关注成人严重 ARDS 的静脉-静脉 ECMO
DOI:
10.1007/s00134-016-4398-0
复制
发表时间:
2016
影响因子:
38.9
通讯作者:
A. Combes
中科院分区:
文献类型:
--
作者:
L. Papazian;M. Herridge;A. Combes
Veno-venous extracorporeal membrane oxygenation (vvECMO) improves oxygenation and promotes carbon dioxide (CO2) removal [1, 2]. In the most severe form of ARDS, ECMO rapidly facilitates the correction of severe derangement in gas exchange and saves time, which allows one to treat the cause of lung injury. Recent advances in ECMO technology have improved safety and promoted its use [3–5].Knowledge of the gas exchange performance of membrane oxygenators is important to help choose the optimal system for patients suffering from acute respiratory failure. In an in vivo study of 317 vvECMO patients supported with four different ECMO systems, Lehle et al.[6] showed that CO2 transfer was dependent on sweep gas flow and blood flow, while O2 transfer was only dependent on blood flow when it was above 3 L/min. The association between ECMO use and the development of thrombocytopenia secondary to circuit-induced platelet activation and aggregation has been suggested, although never carefully evaluated. In a retrospective cohort study of 100 adults who received vvECMO for acute respiratory failure, Abrams et al.[7] demonstrated that the severity of critical illness and platelet count at the time of cannulation were independently associated with the development of severe thrombocytopenia, while the duration of ECMO support was not. A position paper [8] from an international group of experts described the optimal approach to organizing programs and delivering safe and proficient ECMO for acute respiratory failure. They encouraged restraint in the widespread use of ECMO until a better appreciation